Events

  • 05/23/2024
    WuXi AppTec Breaks Ground on New Site in Singapore to Better Support Global Customers
  • 11/08/2023
    WuXi AppTec Named 2023 Global Contract Research, Development and Manufacturing Organization Company of the Year by Frost & Sullivan
  • 06/13/2023
    The Journey to “Druggable”
  • 11/16/2022
    Dr. Tao Guo Addressed a Keynote Speech at the “Medicinal Chemistry Strategy Meeting East Coast USA 2022”-News-Chemistry
  • 06/06/2022
    WuXi AppTec Tianjin Site Opens Rongda New Facility-News-Chemistry
  • September 9, 2025 - September 18, 2025
    Basel, Boston, Copenhagen, and San Diego
    WuXi Science Forums
  • July 27, 2025 - July 31, 2025
    Toronto, Canada
    AAIC 2025
  • July 21, 2025 - July 21, 2025
    London, UK
    21st RSC Nucleic Acids Forum
  • Recent Advances in High Throughput Experimentation (HTE) and Flow Chemistry

    In this webinar, we will present the details of using high throughput experimentation (HTE) to identify reaction conditions for challenging transformations, giving access to a diverse array of medicinal chemistry targets. In parallel to using the conventional batch reactions to synthesize these targets, we also incorporate flow chemistry into the early phase helping reaction up-scaling as well as solving specific chemical problems. Case studies will be provided for both topics.
  • Strategies for Screening and Characterizing Targeted Covalent Inhibitors

    With advancements in drug design, there is resurging interest in drugs that form covalent bonds with their targets, often referred to as targeted covalent inhibitors (TCIs). In this webinar, experts discuss innovative approaches to screen for covalent binders, strategies for the synthesis of covalent warheads, and assays to optimize the ADME/DMPK properties of these molecules.
    This webinar offers a comprehensive perspective on strategies that are crucial for accelerating research focused on covalent drug discovery.
  • Emerging Modalities in Drug Discovery

    In this webinar, we will present the latest advances and challenges facing researchers focused on new and emerging modalities in drug discovery. Topics will include targeted protein degradation, targeted covalent inhibitors, and nucleic acid therapeutics. Our expert speaker, Dr. Tao Guo, will discuss solutions for addressing the complexities in designing, synthesizing, and optimizing these molecules, with an added focus on the special modifications and delivery systems needed for siRNAs and ASOs.

How can we help?

Get in touch with an expert.

Contact us